1. Home
  2. BELFB vs VIR Comparison

BELFB vs VIR Comparison

Compare BELFB & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BELFB
  • VIR
  • Stock Information
  • Founded
  • BELFB 1949
  • VIR 2016
  • Country
  • BELFB United States
  • VIR United States
  • Employees
  • BELFB N/A
  • VIR N/A
  • Industry
  • BELFB
  • VIR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BELFB
  • VIR Health Care
  • Exchange
  • BELFB Nasdaq
  • VIR Nasdaq
  • Market Cap
  • BELFB 971.6M
  • VIR 1.0B
  • IPO Year
  • BELFB N/A
  • VIR 2019
  • Fundamental
  • Price
  • BELFB $74.15
  • VIR $9.26
  • Analyst Decision
  • BELFB Strong Buy
  • VIR Buy
  • Analyst Count
  • BELFB 2
  • VIR 5
  • Target Price
  • BELFB $87.00
  • VIR $36.80
  • AVG Volume (30 Days)
  • BELFB 78.7K
  • VIR 1.1M
  • Earning Date
  • BELFB 10-23-2024
  • VIR 10-31-2024
  • Dividend Yield
  • BELFB 0.38%
  • VIR N/A
  • EPS Growth
  • BELFB N/A
  • VIR N/A
  • EPS
  • BELFB 4.32
  • VIR N/A
  • Revenue
  • BELFB $524,943,000.00
  • VIR $78,618,000.00
  • Revenue This Year
  • BELFB N/A
  • VIR N/A
  • Revenue Next Year
  • BELFB $10.23
  • VIR N/A
  • P/E Ratio
  • BELFB $17.93
  • VIR N/A
  • Revenue Growth
  • BELFB N/A
  • VIR N/A
  • 52 Week Low
  • BELFB $45.75
  • VIR $7.12
  • 52 Week High
  • BELFB $85.91
  • VIR $13.09
  • Technical
  • Relative Strength Index (RSI)
  • BELFB 36.04
  • VIR 73.49
  • Support Level
  • BELFB $75.19
  • VIR $7.24
  • Resistance Level
  • BELFB $78.24
  • VIR $7.82
  • Average True Range (ATR)
  • BELFB 2.47
  • VIR 0.43
  • MACD
  • BELFB -1.30
  • VIR 0.12
  • Stochastic Oscillator
  • BELFB 4.16
  • VIR 81.85

About BELFB Bel Fuse Inc. Class B

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

Share on Social Networks: